First Patient Randomised to EndoNET Breast Cancer Trial

EndoNET is a multi-centre trial that evaluates whether endocrine treatment that prevents the production of oestrogens, when taken for 6 months prior to surgery, will shrink the tumour allowing for a reduction in the extent of surgery. 

for more information visit : EndoNET — Nuffield Department of Surgical Sciences (ox.ac.uk) 

or contact us on 01226 431067 barnsley.research@nhs.net